Weight loss drug semaglutide proven safe and effective for people with schizophrenia
View as a Web Page
News Medical
 
  Schizophrenia Schizophrenia logo  
  The latest schizophrenia news from News Medical  
 Grammatical errors could aid in the early detection of schizophreniaGrammatical errors could aid in the early detection of schizophrenia
 
Meta-analysis shows syntax deficits in schizophrenia, emphasizing the role of language in diagnosis and the development of effective therapeutic strategies.
 
 
 Weight loss drug semaglutide proven safe and effective for people with schizophreniaWeight loss drug semaglutide proven safe and effective for people with schizophrenia
 
Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University of Queensland researchers have found.
 
   Weekly risperidone capsule delivers consistent drug levels for schizophrenia patientsWeekly risperidone capsule delivers consistent drug levels for schizophrenia patients
 
For many patients with schizophrenia, other psychiatric illnesses, or diseases such as hypertension and asthma, it can be difficult to take their medicine every day.
 
   Taking antipsychotic medications lowers crash risk for drivers with schizophreniaTaking antipsychotic medications lowers crash risk for drivers with schizophrenia
 
Taking antipsychotic medications as prescribed lowers the risk of a car crash for drivers with schizophrenia, according to new research published in CMAJ (Canadian Medical Association Journal)
 
   Symptom provocation may boost effectiveness of repetitive transcranial magnetic stimulationSymptom provocation may boost effectiveness of repetitive transcranial magnetic stimulation
 
A new study in JAMA Psychiatry makes the case that symptom provocation may significantly improve the clinical effectiveness of repetitive transcranial magnetic stimulation (rTMS), a noninvasive brain stimulation method used to treat depression, obsessive-compulsive disorder (OCD) and nicotine dependence.
 
 Study reveals how genetic differences in TRIO affect neurodevelopment
 
Study reveals how genetic differences in TRIO affect neurodevelopmentResearchers have identified how variations in a gene called TRIO can influence brain functions and result in distinct neurodevelopmental diseases.
 
 
 UC Davis study links specific microRNAs to mental and neurological disorders
 
UC Davis study links specific microRNAs to mental and neurological disordersA study in Nature Aging from researchers at the UC Davis School of Medicine has identified specific microRNAs - non-coding RNAs that regulate gene expression within cells - that likely contribute to bipolar disorder, depression, schizophrenia, post-traumatic stress disorder (PTSD) and Parkinson's disease.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025